The improvement of breast cancer prognosis accuracy from integrated gene expression and clinical data

Expert Systems with Applications

Volumn 39, Issue 5, 2012, Pages 4785-4795

  Chen, Austin H ^a   Yang, Chenyin ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Breast cancer prognosis; Cancer classification; Clinical data; Gene expression; Gene selection; Genetic algorithm; Support vector machine

Indexed keywords

BREAST CANCER; CANCER CLASSIFICATION; CLINICAL DATA; GENE SELECTION; SUPPORT VECTOR;

DISEASES; FORECASTING; GENETIC ALGORITHMS; SELF ORGANIZING MAPS; SUPPORT VECTOR MACHINES;

GENE EXPRESSION;

EID: 84855888449     PISSN: 09574174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eswa.2011.09.144     Document Type: Article

References (45)

1. M. Ahmed, and N. Rahman ATM and breast cancer susceptibility Oncogene 25 2006 5906 5911
2. G. Alexe, S. Alexe, D.E. Axelrod, T.O. Bonates, I.I. Lozina, and M. Reiss Breast cancer prognosis by combinatorial analysis of gene expression data Breast Cancer Research 8 2006 R41
3. F. Bertucci, N. Borie, C. Ginestier, A. Groulet, E. Charafe-Jauffret, and J. Adélaïde Identification and validation of an ERBB2 gene expression signature in breast cancers Oncogene 23 2004 2564 2575
4. A.L. Boulesteix, C. Porzelius, and M. Daumer Microarray-based classification and clinical predictors: on combined classifiers and additional predictive value BIOINFORMATICS 24 15 2008 1698 1706
5. J.R. Caldeira, E.C. Prando, F.C. Quevedo, F.A. Neto, C.A. Rainho, and S.R. Rogatto CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer BMC Cancer 6 2006 48
6. Chang, C. C. & Lin, C. J. (2005). LIBSVM - A library for support vector machines. .
7. Chen, T.; He, H. L.; Church, G. M. (1999). Modeling Gene Expression with differential equations. In Proceedings of Pacific Symposium on Biocomputing (pp. 29-40).
8. J.J. Chen, K. Peck, T.M. Hong, S.C. Yang, Y.P. Sher, and J.Y. Shih Global analysis of gene expression in invasion by a lung cancer model Cancer Research 5223-5230 July 1 2001
9. N. Cristianini, and J. Shawe-Taylor An introduction to support vector machines 2000 Cambridge University Press Cambridge
10. J.A. Fernandez Pierna, V. Baeten, A. Michotte Renier, R.P. Cogdill, and P. Dardenne Combination of support vector machines (SVM) and near-infrared (NIR) imaging spectroscopy for the detection of meat and bone meal (MBM) in compound feeds Journal of Chemometrics 18 7-8 2004 341 349
11. C. Forcet, S. Etienne-Manneville, H. Gaude, L. Fournier, S. Debilly, and M. Salmi Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity Human Molecular Genetics 14 10 2005 1283
12. B. Frank, K. Hemminki, A. Meindl, B. Wappenschmidt, C. Sutter, and M. Kiechle BRIP1 (BACH1) variants and familial breast cancer risk: A case-control study BMC Cancer 7 2007 83
13. N. Friedman, M. Linial, I. Nachman, and D. Pe'er Using Bayesian networks to analyze expression data Journal of Computational Biology 7 3-4 2000 601 620
14. Olivier Gevaert, Frank De Smet, Dirk Timmerman, Yves Moreau, and Bart De Moor Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks BIOINFORMATICS 22 14 2006 e184 e190
15. B.T. Greer, and J. Khan Diagnostic classification of cancer using DNA microarrays and artificial intelligence Annals of the New York Academy of Sciences 1020 2004 49 66
16. Gunn, S.R. (2004). Support vector machines for classification and regression. Technicalreport, Image speechandintelligent systems research group, University of Southampton, UK,. Available on .
17. K. Heikkinen, S.M. Karppinen, Y. Soini, M. Mäkinen, and R. Winqvist Mutation screening of Mre11 complex genes: Indication of RAD50 involvement in breast and ovarian cancer susceptibility Journal of Medical Genetics 40 2003 e131
18. K. Heikkinen, K. Rapakko, S.M. Karppinen, H. Erkko, S. Knuutila, and T. Lundán RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability Carcinogenesis 27 8 2006 1593 1599
19. P. Helman, R. Veroff, S.R. Atlas, and C. Willman A Bayesian network classification methodology for gene expression data Journal of Computational Biology 11 2004 581 615
20. G.E. Herman, E. Butter, B. Enrile, M. Pastore, T.W. Prior, and A. Sommer Increasing knowledge of PTEN germline mutations; two additional patients with autism and macrocephaly American Journal of Medical Genetics Part A 143A 2007 589 593
21. C. Huang, and C. Wang A GA-based feature selection and parameters optimization for support vector machines Expert Systems with Applications 31 2 2006 231 240
22. S.M. Karppinen, R.B. Barkardottir, K. Backenhorn, T. Sydenham, K. Syrjäkoski, and J. Schleutker Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: Enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies Journal of Medical Genetics 43 2006 856 862
23. V. Kecman Learning and soft computing 2001 The MIT Press Cambridge, MA
24. J. Khan, J.S. Wei, M. Ringnér, L.H. Saal, M. Ladanyi, and F. Westermann Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks Nature Medicine 7 2001 673 679
25. Lise Anne Dale Borresen. TP53 and Breast Cancer HUMAN MUTATION 21 2003 292 300
26. L. Li, C.R. Weinberg, T.A. Darden, and L.G. Pedersen Gene selection for sample classification based on gene expression data: Study of sensitivity to choice of parameters of the GA-KNN method Bioinformatics 17 2001 1131 1142
27. Lose, F.; Lovelock, P.; Chenevix-Trench, G.; Mann, G. J.; Pupo, G. M.; Spurdle, A. B. (2006). Variation in the RAD51 gene and familial breast cancer. Breast Cancer Research.
28. R.Z. Luo, X. Fang, R. Marquez, S.Y. Liu, G.B. Mills, and W.S. Liao ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers Oncogene 22 2003 2897 2909
29. K. Metcalfe, H.T. Lynch, P. Ghadirian, N. Tung, I. Olivotto, and E. Warner Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers Journal of Clinical Oncology 22 2004 2328 2335
30. S. Michiels, S. Koscielny, and C. Hill Prediction of cancer outcome with microarrays: A multiple random validation strategy Lancet 365 2005 488 492
31. M. Morley, C.M. Molony, T.M. Weber, J.L. Devlin, K.G. Ewens, and R.S. Spielman Genetic analysis of genome-wide variation in human gene expression Nature 430 2004 743 747 12 August
32. S. Ramaswamy, P. Tamayo, R. Rifkin, S. Mukherjee, C.H. Yeang, and M. Angelo Multiclass cancer diagnosis using tumor gene expression signatures Proceedings of the National Academy of Sciences of the United States of America 98 2001 15149 15154
33. C.J. Savoie, S. Aburatani, S. Watanabe, Y. Eguchi, S. Muta, and S. Imoto Use of gene networks from full genome microarray libraries to identify functionally relevant drug-affected gene s and gene regulation cascades DNA Research 10 2003 19 25
34. B. Schölkopf, I. Guyon, and J. Weston Statistical learning and kernel methods 2000 MIT Press Cambridge, MA
35. E. Segal, N. Friedman, D. Koller, and A. Regev A module map showing conditional activity of expression modules in cancer Nature Genetics 36 2004 1090 1098
36. H. Song, S.J. Ramus, S.K. Kjaer, E. Hogdall, R.A. Dicioccio, and A.S. Whittemore Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer PLoS ONE 2 3 2007 e268
37. C. Sotiriou, S.Y. Neo, L.M. McShane, E.L. Korn, P.M. Long, and A. Jazaeri Breast cancer classification and prognosis based on gene expression profiles from a population-based study PNAS 100 2003 10393 10398
38. T. Soussi, and C. Béroud Significance of TP53 mutations in human cancer; a critical analysis of mutations at CpG dinucleotides HUMAN MUTATION 21 2003 192 200
39. J. Steffen, D. Nowakowska, A. Niwińska, D. Czapczak, A. Kluska, and M. Piatkowska Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland International Journal of Cancer 119 2006 472 475
40. Aik Choon Tan, and David Gilbert Ensemble machine learning on gene expression data for cancer classification Bioinformatics 2 3 Suppl 2003 S75 S83
41. J. Tommiska, S. Seal, A. Renwick, R. Barfoot, L. Baskcomb, and H. Jayatilake Evaluation of RAD50 in familial breast cancer predisposition International Journal of Cancer 118 2006 2911 2916
42. M.J. van de Vijver, Y.D. He, L.J. van't Veer, H. Dai, A.A. Hart, and D.W. Voskuil A Gene-expression signature as a predictor of survival in breast cancer New England Journal of Medicine 347 25 2002 December 19
43. L.J. van 't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, and M. Mao Gene expression profiling predicts clinical outcome in breast cancer Nature 415 2002 530 536
44. T. Walsh, S. Casadei, K.H. Coats, E. Swisher, S.M. Stray, and J. Higgins Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer JAMA 295 2006 1379 1388
45. C. Yang, V. Ionescu-Tiba, K. Burns, M. Gadd, L. Zukerberg, and D.N. Louis The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer American Journal of Pathology 164 2004 1031 1038